Women’s Health Principal & CEO SenoGuard™
Ms. Tucker is the CEO for a novel breast cancer prevention company being developed with MED1. Ms. Tucker has held executive level positions with both corporate healthcare companies such as
Johnson and Johnson and American Medical Optics, as well as early stage privately held companies where she helped develop an launch disruptive medical technologies. Diana pioneered the utilization of social media to breast cancer patients as Global Head of Marketing for Agendia, driving early stage revenues from $5M to $25M in 2 years, in spite of the technology having a negative impact on physician’s revenues. Ms. Tucker passion is and has always been on new medical technology in women’s health and breast cancer. She was a contributing writer on emerging medical technologies and their impact on marketplaces for Thomson-Reuters Medical Device Daily. She holds a BS in Molecular & Cellular Biology from UCI and an MBA from Pepperdine.